The global Endoscopic Vessel Harvesting System Market size was estimated at USD 1,881.7 million in 2016 and is expected to grow at a CAGR of 6.1% over the forecast period. Increasing incidences of cardiovascular disorders leads to surge in demand for EVH. According to WHO, globally CVD is the leading cause of death. It was estimated that approximately 17.7 million people died from CVD’s in 2015 that represents 31% of all global deaths. In addition, there is a rising prevalence of the risk associated with CVD including obesity, diabetes mellitus, and high blood pressure, which is further expected to boost demand for these devices.
Request free sample to get a complete analysis of top-performing
companies: https://www.millioninsights.com/industry-reports/endoscopic-vessel-harvesting-evh-system-market/request-sample
Key Players:
Some of the key participants of
global EVH system market include, Olympus Corporation; Maquet Holding B.V.
& Co. KG; Terumo Cardiovascular Systems Corporation; Saphena Medical, Inc.;
Medical Instruments S.p.a; LivaNova plc.; Cardio Medical GmbH; Sorin Group,
Inc. and Med Europe S.r.I.
Growth Drivers:
Technological advancements
pertaining to cardiovascular medical devices is one of the pivotal factors
anticipated to propel the growth of the EVH systems. Growing investments by the
major players in this market pertaining to device upgradation and new product
launch is also amongst few factors driving the demand. For instance, Maquet
Cardiovascular LLC launched advanced VASOVIEW Technology for Endoscopic Vessel
procedures in Cardiac Surgery. In addition, increasing R&D activities with
surging number of new product launches is one of the factor that expected to
impel the market growth over forecast period.
Growing preferance for minimally
invasive procedures and cost efficient surgeries is further boosts demand for
EVH systems. Some of the advantages associated with these devices are minimum
recovery time , reducing post surgery infection risk, and leaves minimal
surgery scars. For example, Sorin Group launched the VascuClear EVH System in
2011, which reduces the patient’s pain, infection rates, recovery time, and
scarring. Also, rising geriatric population and growing number of awareness
programs related to cardiac health contribute to the demand for EVH system.
Product Insights
On the basis of product, the
market is segmented as reusable and disposable endoscopic vessel harvesting
systems. The reusable segment held the majority of the revenue share and was
valued at USD 1,242.4 million in 2016. Some of the key factors such as high
commercial availability and maximum adoption of these devices by the hospitals
are some of the key factors that can be accounted for the major market share.
In addition, growing demand for EVH in Coronary Artery Bypass Graft (CABG)
surgeries especially in emerging economies is another factor rising the demand
for EVH systems in the market. Few of the commercially available products are
Venapax Vein Harvesting, Endoperfect systems, VirtuoSaph plus EVH systems,
Endoperfect systems, and Cardiovision EVH systems. Some of the major players in
the market include Terumo Cardiovascular Group; Cardio Medical GmbH; Saphena
Medical; Inc.; and Liva Nova plc.
Browse Detailed Research Insights with Table of Content: https://www.millioninsights.com/industry-reports/endoscopic-vessel-harvesting-evh-system-market
No comments:
Post a Comment